| Old Articles: <Older 30261-30270 Newer> |
|---|
 |
The Motley Fool
May 20, 2008
Selena Maranjian |
Who's Buying Back Shares? American corporations have been busy recently buying back lots of their own shares on the open market. Read on for the top ten biggest repurchasers of 2007.   |
The Motley Fool
May 20, 2008
Rick Aristotle Munarriz |
4 Reasons Amazon.com Will Rule the World Shares of Amazon.com soar following an upgrade by a Goldman Sachs analyst. |
The Motley Fool
May 20, 2008
Rich Smith |
Lockheed's F-16: Wings Not Clipped Yet Rumors of the fighter jet's demise have been greatly exaggerated. |
The Motley Fool
May 20, 2008
Richard Gibbons |
The Growth Stocks You Should Buy One critical factor separates great growth stocks from the ones that crash and burn. Read on to see what it is. |
The Motley Fool
May 20, 2008
Rich Smith |
Superjet: Kryptonite for Embraer? The Brazilian plane maker Embraer had been doing so well recently that it was bound to attract interest -- and competition -- and it has, from Russia's United Aircraft Corporation. |
The Motley Fool
May 20, 2008
Tim Beyers |
The Company That Could Destroy Google? The company that could destroy Google is a far-off start-up whose sole purpose will be to make your classic Google search obsolete. |
The Motley Fool
May 20, 2008
Mac Greer |
Fool Video: The Next Disney and 5 Stocks for May In recent years, May has been a good month for shares of Cisco, eBay, and Research In Motion. What other stocks bloom in May? Watch this video to find out. |
Information Today
May 19, 2008 |
CBS Corp. to Acquire CNET Networks, Inc. CBS will make a cash tender offer for all issued and outstanding shares of CNET Networks for $11.50 per share. CNET Networks' sites will be combined with CBS's stable of interactive businesses. |
The Motley Fool
May 19, 2008
Colleen Paulson |
Do You Want to Invest Like the Yankees? Winning in the market isn't as subjective as you may think. |
The Motley Fool
May 19, 2008
Brian Orelli |
What Will Icahn Do With Amylin? Carl Icahn recently took an initial position now worth around $200 million in Amylin Pharmaceuticals, and stockholders must be wondering about his motivation for the purchase. |
| <Older 30261-30270 Newer> Return to current articles. |
